Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammaplasty | 14 | 2025 | 124 | 4.860 |
Why?
|
| Mastectomy | 21 | 2025 | 270 | 4.140 |
Why?
|
| Breast Implants | 7 | 2025 | 28 | 3.560 |
Why?
|
| Breast Implantation | 7 | 2025 | 15 | 3.380 |
Why?
|
| Breast Neoplasms | 24 | 2025 | 3155 | 3.020 |
Why?
|
| Pectoralis Muscles | 2 | 2025 | 9 | 1.130 |
Why?
|
| Quality of Life | 6 | 2025 | 1816 | 1.040 |
Why?
|
| Surgical Flaps | 4 | 2015 | 259 | 1.000 |
Why?
|
| Reoperation | 5 | 2024 | 707 | 0.960 |
Why?
|
| Nipples | 4 | 2020 | 38 | 0.780 |
Why?
|
| Wound Healing | 5 | 2008 | 378 | 0.720 |
Why?
|
| Unilateral Breast Neoplasms | 1 | 2020 | 5 | 0.670 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2020 | 286 | 0.660 |
Why?
|
| Postoperative Complications | 7 | 2023 | 2592 | 0.630 |
Why?
|
| Free Tissue Flaps | 1 | 2018 | 55 | 0.540 |
Why?
|
| Mastectomy, Subcutaneous | 1 | 2016 | 8 | 0.500 |
Why?
|
| Female | 30 | 2025 | 49868 | 0.500 |
Why?
|
| Prostheses and Implants | 2 | 2008 | 132 | 0.480 |
Why?
|
| Surgical Wound Infection | 2 | 2015 | 237 | 0.470 |
Why?
|
| Age Factors | 3 | 2015 | 1957 | 0.470 |
Why?
|
| Patient Satisfaction | 3 | 2016 | 514 | 0.460 |
Why?
|
| Prophylactic Surgical Procedures | 1 | 2015 | 7 | 0.460 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2015 | 166 | 0.440 |
Why?
|
| Cicatrix, Hypertrophic | 3 | 2008 | 8 | 0.420 |
Why?
|
| Mastectomy, Segmental | 3 | 2021 | 108 | 0.420 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 296 | 0.400 |
Why?
|
| Facial Paralysis | 1 | 2013 | 23 | 0.390 |
Why?
|
| Prophylactic Mastectomy | 3 | 2018 | 13 | 0.390 |
Why?
|
| Humans | 33 | 2025 | 95798 | 0.370 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 171 | 0.370 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2012 | 126 | 0.350 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 483 | 0.310 |
Why?
|
| Middle Aged | 16 | 2025 | 28206 | 0.300 |
Why?
|
| Retrospective Studies | 9 | 2023 | 10273 | 0.300 |
Why?
|
| Adult | 15 | 2023 | 28578 | 0.300 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2008 | 16 | 0.290 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2008 | 67 | 0.280 |
Why?
|
| Ultrasonography, Doppler | 1 | 2008 | 83 | 0.270 |
Why?
|
| Macrophage-1 Antigen | 1 | 2007 | 18 | 0.270 |
Why?
|
| Ultrasonography, Interventional | 1 | 2008 | 125 | 0.260 |
Why?
|
| Mononeuropathies | 1 | 2007 | 8 | 0.260 |
Why?
|
| Surveys and Questionnaires | 3 | 2025 | 2859 | 0.260 |
Why?
|
| Aged | 11 | 2025 | 20848 | 0.250 |
Why?
|
| Databases, Factual | 3 | 2016 | 1010 | 0.250 |
Why?
|
| Healthcare Disparities | 1 | 2012 | 491 | 0.250 |
Why?
|
| Prospective Studies | 4 | 2025 | 4664 | 0.250 |
Why?
|
| Arthroplasty, Replacement | 1 | 2007 | 38 | 0.250 |
Why?
|
| Pressure Ulcer | 1 | 2007 | 44 | 0.250 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2005 | 6 | 0.240 |
Why?
|
| Monocytes | 1 | 2007 | 220 | 0.240 |
Why?
|
| Suture Techniques | 2 | 2009 | 143 | 0.240 |
Why?
|
| Shoulder Joint | 1 | 2007 | 100 | 0.230 |
Why?
|
| Reperfusion Injury | 1 | 2007 | 148 | 0.230 |
Why?
|
| Ilium | 1 | 2005 | 31 | 0.230 |
Why?
|
| Abdominal Wall | 1 | 2005 | 32 | 0.230 |
Why?
|
| Surgical Mesh | 1 | 2005 | 125 | 0.220 |
Why?
|
| Ischemia | 2 | 2004 | 256 | 0.210 |
Why?
|
| Up-Regulation | 1 | 2007 | 740 | 0.210 |
Why?
|
| Breast Cancer Lymphedema | 1 | 2023 | 5 | 0.210 |
Why?
|
| Tissue Expansion Devices | 1 | 2023 | 8 | 0.210 |
Why?
|
| RNA, Messenger | 2 | 2008 | 2089 | 0.200 |
Why?
|
| Bone Neoplasms | 1 | 2005 | 316 | 0.200 |
Why?
|
| Skin Ulcer | 1 | 2003 | 27 | 0.190 |
Why?
|
| Lymphedema | 1 | 2023 | 84 | 0.190 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2022 | 84 | 0.180 |
Why?
|
| Socioeconomic Factors | 2 | 2016 | 640 | 0.180 |
Why?
|
| Follow-Up Studies | 3 | 2025 | 3904 | 0.180 |
Why?
|
| Acellular Dermis | 1 | 2021 | 7 | 0.180 |
Why?
|
| Tissue Expansion | 1 | 2021 | 19 | 0.180 |
Why?
|
| Length of Stay | 2 | 2015 | 833 | 0.170 |
Why?
|
| United States | 6 | 2018 | 7764 | 0.170 |
Why?
|
| Patient Discharge | 1 | 2023 | 361 | 0.160 |
Why?
|
| Organ Sparing Treatments | 1 | 2020 | 47 | 0.160 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 7215 | 0.150 |
Why?
|
| Rabbits | 4 | 2008 | 639 | 0.140 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 2061 | 0.140 |
Why?
|
| Bone Transplantation | 1 | 2018 | 79 | 0.140 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 216 | 0.130 |
Why?
|
| Skin Transplantation | 1 | 2018 | 193 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 847 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1176 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2020 | 1463 | 0.120 |
Why?
|
| Esthetics | 1 | 2016 | 50 | 0.120 |
Why?
|
| Population Surveillance | 1 | 2016 | 218 | 0.110 |
Why?
|
| Graft Survival | 1 | 2018 | 942 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 186 | 0.110 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 125 | 0.110 |
Why?
|
| Carcinoma in Situ | 1 | 2015 | 53 | 0.110 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1957 | 0.110 |
Why?
|
| Community Health Planning | 2 | 2024 | 22 | 0.100 |
Why?
|
| Blood Transfusion | 1 | 2015 | 180 | 0.100 |
Why?
|
| Transplantation, Autologous | 1 | 2015 | 361 | 0.100 |
Why?
|
| Genes, BRCA2 | 1 | 2014 | 162 | 0.100 |
Why?
|
| Risk | 1 | 2015 | 665 | 0.100 |
Why?
|
| Genes, BRCA1 | 1 | 2014 | 192 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 378 | 0.100 |
Why?
|
| Time-to-Treatment | 1 | 2014 | 140 | 0.100 |
Why?
|
| Face | 1 | 2013 | 114 | 0.090 |
Why?
|
| Patient Selection | 1 | 2016 | 708 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2012 | 295 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2024 | 816 | 0.090 |
Why?
|
| Surgeons | 1 | 2016 | 298 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 569 | 0.090 |
Why?
|
| Comorbidity | 1 | 2015 | 1011 | 0.080 |
Why?
|
| Sepsis | 1 | 2015 | 389 | 0.080 |
Why?
|
| Rats | 3 | 2007 | 4154 | 0.080 |
Why?
|
| Granulation Tissue | 2 | 2007 | 15 | 0.080 |
Why?
|
| Animals | 7 | 2008 | 28888 | 0.070 |
Why?
|
| Time Factors | 4 | 2016 | 5561 | 0.070 |
Why?
|
| Logistic Models | 1 | 2012 | 1267 | 0.070 |
Why?
|
| Esophagus | 1 | 2009 | 111 | 0.070 |
Why?
|
| Esophagectomy | 1 | 2009 | 92 | 0.070 |
Why?
|
| Young Adult | 2 | 2021 | 7026 | 0.070 |
Why?
|
| Ultraviolet Therapy | 1 | 2008 | 17 | 0.070 |
Why?
|
| False Negative Reactions | 1 | 2008 | 61 | 0.070 |
Why?
|
| Veins | 1 | 2008 | 94 | 0.070 |
Why?
|
| Immunochemistry | 1 | 2007 | 18 | 0.070 |
Why?
|
| Smad Proteins | 1 | 2007 | 44 | 0.070 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2007 | 52 | 0.070 |
Why?
|
| Heme Oxygenase-1 | 1 | 2007 | 22 | 0.060 |
Why?
|
| Humerus | 1 | 2007 | 32 | 0.060 |
Why?
|
| Child | 1 | 2018 | 7618 | 0.060 |
Why?
|
| Wounds, Penetrating | 1 | 2007 | 56 | 0.060 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2007 | 46 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2007 | 42 | 0.060 |
Why?
|
| Debridement | 1 | 2007 | 60 | 0.060 |
Why?
|
| Monitoring, Physiologic | 1 | 2008 | 273 | 0.060 |
Why?
|
| Rotator Cuff | 1 | 2007 | 51 | 0.060 |
Why?
|
| Esophageal Neoplasms | 1 | 2009 | 345 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2007 | 118 | 0.060 |
Why?
|
| Urinary Fistula | 1 | 2006 | 7 | 0.060 |
Why?
|
| Male | 5 | 2018 | 45685 | 0.060 |
Why?
|
| Syndrome | 1 | 2007 | 450 | 0.060 |
Why?
|
| Urethral Diseases | 1 | 2006 | 14 | 0.060 |
Why?
|
| Urethral Stricture | 1 | 2006 | 15 | 0.060 |
Why?
|
| Rectal Fistula | 1 | 2006 | 19 | 0.060 |
Why?
|
| Mouth Mucosa | 1 | 2006 | 71 | 0.060 |
Why?
|
| Disease Models, Animal | 4 | 2008 | 2534 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 403 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 349 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 930 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 1267 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 2605 | 0.050 |
Why?
|
| Macrophages | 1 | 2007 | 623 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2007 | 983 | 0.050 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2023 | 86 | 0.050 |
Why?
|
| Axilla | 1 | 2023 | 110 | 0.050 |
Why?
|
| Necrosis | 1 | 2023 | 210 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2007 | 2161 | 0.050 |
Why?
|
| Lymph Node Excision | 1 | 2023 | 234 | 0.050 |
Why?
|
| Models, Animal | 1 | 2003 | 286 | 0.040 |
Why?
|
| Skin | 1 | 2004 | 604 | 0.040 |
Why?
|
| Apoptosis | 1 | 2007 | 1756 | 0.040 |
Why?
|
| Contraindications, Procedure | 1 | 2020 | 7 | 0.040 |
Why?
|
| Collagen | 1 | 2021 | 306 | 0.040 |
Why?
|
| Aging | 1 | 2004 | 766 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2023 | 9167 | 0.040 |
Why?
|
| Research Design | 1 | 2003 | 630 | 0.040 |
Why?
|
| Fees and Charges | 1 | 2018 | 14 | 0.040 |
Why?
|
| Hospital Charges | 1 | 2018 | 32 | 0.040 |
Why?
|
| Ear | 2 | 2008 | 17 | 0.030 |
Why?
|
| Emotions | 1 | 2021 | 377 | 0.030 |
Why?
|
| Propensity Score | 1 | 2018 | 180 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 1714 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1878 | 0.030 |
Why?
|
| Self Report | 1 | 2016 | 328 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 936 | 0.030 |
Why?
|
| Heterozygote | 1 | 2014 | 382 | 0.020 |
Why?
|
| Mice | 1 | 2007 | 12536 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2014 | 182 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 404 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 3106 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2014 | 386 | 0.020 |
Why?
|
| Physicians | 1 | 2018 | 706 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 491 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 2042 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2009 | 85 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 9873 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2009 | 284 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 3990 | 0.020 |
Why?
|
| Fluorescein | 1 | 2004 | 14 | 0.010 |
Why?
|
| Urologic Surgical Procedures | 1 | 2006 | 152 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2004 | 165 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 4374 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 1319 | 0.010 |
Why?
|
| Contrast Media | 1 | 2004 | 1096 | 0.010 |
Why?
|